REACH impact claims overblown, says Tufts study
A study performed at Tufts University in the US, commissioned by the Nordic Council of Ministers, has downplayed the impact of the controversial REACH legislation on the European chemicals industry.
Archives for October 18, 2004
Ignoring downstream processing hikes costs
The contract manufacturing market for biologicals will more than double over the next six years, but production costs are higher than necessary because 'downstream' processing is being ignored.
SCOLR advances clinical projects
Drug delivery company SCOLR Pharma has signed a deal to manufacture its candidate decongestant product based on pseudoephedrine, keeping it on track to start clinical trials early next year.
'Green' metallising technology for packaging
Pfizer has called on the services of an Australian technology company to create a metallised packaging for its Sudafed brand of cough/cold products that does not come with an environmental price tag.
Cambrex licenses probes for microbiological QC
A Cambrex subsidiary has formed an alliance with Epoch Biosciences to apply a technology usually applied in genomic analysis to microbiological quality control for manufacturing processes.